To date, the majority of animal studies of the disease have relied upon a previously described cbs null knockout mouse model that suffers from growth retardation and severe hepatopathy with 90% of cbs null mice dying during the first 2 weeks of neonatal life [2]. This evidence concerns the gene CBS and Decreased liver function.